LABCORP HOLDINGS INC. — Director's Dealing 2016

Feb 16, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LABORATORY CORP OF AMERICA HOLDINGS (LH)
CIK: 0000920148
Period of Report: 2016-02-11

Reporting Person: Boyle James T. Jr. (EVP,CEO of LabCorp Diagnostics)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-02-11	Common Stock	M	4057	—	Acquired	27511	Direct
2016-02-11	Common Stock	F	1345	$101.40	Disposed	26166	Direct
2016-02-12	Common Stock	S	2712	$101.67	Disposed	23454	Direct
2016-02-12	Common Stock	M	2837	—	Acquired	26291	Direct
2016-02-12	Common Stock	F	942	$103.02	Disposed	25349	Direct
2016-02-12	Common Stock	M	3334	—	Acquired	28683	Direct
2016-02-12	Common Stock	F	1174	$103.02	Disposed	27509	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-02-11	Restricted Stock Unit	$	M	4057	Disposed		Common Stock (4057)	Direct
2016-02-12	Restricted Stock Unit	$	M	2837	Disposed		Common Stock (2837)	Direct
2016-02-12	Restricted Stock Unit	$	M	3334	Disposed		Common Stock (3334)	Direct

Footnotes

F1: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock.

F2: Stock withholding to satisfy tax withholding obligations.

F3: Pursuant to a plan in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934.

F4: The Restricted Stock Units vest in three equal annual installments beginning on 2/11/2015.

F5: This number reflects the aggregate number of Restricted Stock Units held by the reporting person.

F6: The Restricted Stock Units vest in three equal annual installments beginning on 2/12/2014.